Tidal Investments LLC Acquires Shares of 13,113 Agilon Health, Inc. $AGL

Key Points

• Tidal Investments acquired 13,113 shares of Agilon Health worth approximately $1.405 million, representing about 0.08% of the company. Several other institutional investors also increased or initiated positions.
• Analyst sentiment remains mixed: Agilon has an overall “Hold” rating, with six Buy, seven Hold, and two Sell recommendations, and an average price target of $102.25.
• Agilon reported quarterly revenue of $1.49 billion and earnings of $1.04 per share, exceeding consensus estimates, though the company continues to post negative net margins and return on equity.

Tidal Investments LLC bought a new stake in Agilon Health, Inc. (NYSE:AGL - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 13,113 shares of the company's stock, valued at approximately $1,405,000. Tidal Investments LLC owned approximately 0.08% of Agilon Health as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. North Peak Capital Management LLC grew its position in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company's stock valued at $26,267,000 after acquiring an additional 3,715,460 shares in the last quarter. Rubicon Founders LLC acquired a new position in shares of Agilon Health during the second quarter worth $11,290,448. Bank of New York Mellon Corp boosted its stake in shares of Agilon Health by 9.5% in the second quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company's stock valued at $3,787,000 after purchasing an additional 3,074 shares during the period. UBS Group AG boosted its stake in shares of Agilon Health by 250.7% in the fourth quarter. UBS Group AG now owns 3,395,366 shares of the company's stock valued at $2,339,000 after purchasing an additional 2,427,136 shares during the period. Finally, Great Lakes Advisors LLC acquired a new stake in Agilon Health during the 2nd quarter valued at $702,000.

Analyst Ratings Changes

Several equities research analysts recently issued reports on AGL shares. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an "equal weight" rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. upped their price objective on shares of Agilon Health from $31.00 to $85.00 and gave the company an "underweight" rating in a research report on Monday, August 24th. Weiss Ratings restated a "sell (e+)" rating on shares of Agilon Health in a research note on Monday, August 24th. Sanford C. Bernstein raised Agilon Health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $86.00 to $125.00 in a research report on Tuesday. Finally, Citigroup upgraded Agilon Health from a "sell" rating to a "neutral" rating and boosted their price target for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $102.25.

Agilon Health Stock Performance

Shares of AGL stock opened at $88.95 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. Agilon Health, Inc. has a one year low of $7.48 and a one year high of $133.04. The company's 50-day simple moving average is $97.64 and its 200-day simple moving average is $71.79. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.23 and a beta of 3.02.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Equities analysts anticipate that Agilon Health, Inc. will post -2.9 earnings per share for the current fiscal year.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.